Food Allergy vs Food Intolerance: Key Differences Explained

32 Million Americans Have Food Allergies

Food allergy affects approximately 32 million Americans — 26 million adults and 5.6 million children — according to a 2019 JAMA Network Open survey. But a crucial distinction is frequently missed: not everyone who reacts adversely to a food has a true allergy. True food allergy is an immune-mediated response. Food intolerance is not. Conflating the two leads to unnecessary dietary restriction, missed diagnoses, and failure to carry life-saving epinephrine.

IgE-Mediated Allergy — The True Allergic Response

Classic food allergy is IgE-mediated. On first exposure to an allergen — peanut protein, for example — sensitized individuals produce allergen-specific IgE antibodies that bind to mast cells and basophils. On re-exposure, the allergen cross-links these cell-bound IgE molecules, triggering degranulation and release of histamine, prostaglandins, leukotrienes, and cytokines. Symptoms emerge within minutes.

Anaphylaxis — the life-threatening systemic reaction — requires rapid epinephrine injection (intramuscular, anterolateral thigh) and emergency medical care. Antihistamines do not treat anaphylaxis; they address only histamine-mediated symptoms (urticaria, itching) and are dangerously insufficient for respiratory compromise or cardiovascular collapse. The eight major allergens responsible for 90% of food-allergic reactions in the United States are: milk, eggs, fish, shellfish, tree nuts, peanuts, wheat, and soybeans. Sesame became the ninth FDA-recognized major allergen in 2023.

Non-IgE-Mediated Reactions — Delayed and Difficult

Non-IgE-mediated reactions involve different immune pathways — often T-cell mediated — and present hours to days after exposure. Food protein-induced enterocolitis syndrome (FPIES), eosinophilic esophagitis, and allergic proctocolitis fall into this category. They lack the classic immediate urticaria and anaphylaxis of IgE reactions; instead, symptoms are gastrointestinal — projectile vomiting, bloody stool, chronic abdominal pain. Diagnosis is delayed on average 2–4 years for eosinophilic esophagitis because endoscopy is required for confirmation.

Food Intolerance — No Immune Involvement

Food intolerance is a metabolic or pharmacological reaction that does not involve the immune system. Lactose intolerance — the most common example, affecting 65% of the global adult population — results from insufficient lactase enzyme production, allowing undigested lactose to reach the colon where fermentation by bacteria produces bloating, gas, and diarrhea. Fructose malabsorption follows a similar mechanism. Caffeine sensitivity is pharmacological. Sulfite reactions in wine-sensitive individuals are not IgE-mediated for most affected people.

FODMAP Intolerance — Not an Allergy

FODMAP intolerance is a form of food intolerance increasingly recognized in irritable bowel syndrome. FODMAPs — Fermentable Oligosaccharides, Disaccharides, Monosaccharides, And Polyols — are short-chain carbohydrates that are poorly absorbed in the small intestine. They pass to the colon, draw water osmotically, and are fermented by colonic bacteria, producing hydrogen, methane, and carbon dioxide. The result: bloating, distension, cramping, and altered bowel habit.

A low-FODMAP diet — developed at Monash University, Melbourne — produces symptom improvement in 50–80% of IBS patients in randomized trials. It is a temporary elimination diet, not a permanent restriction; after 4–8 weeks, individual FODMAPs are reintroduced systematically to identify personal triggers. Common high-FODMAP foods include wheat, onions, garlic, apples, pears, honey, cow's milk, and legumes.

Diagnosing Food Allergy — Tests and Their Limits

• Skin prick test (SPT): a drop of allergen extract is placed on the forearm and the skin pricked through it. A wheal ≥3 mm larger than the negative control at 15 minutes suggests sensitization. Positive predictive value is approximately 50%; many sensitized people tolerate the food without symptoms.
• Specific IgE blood test (sIgE, formerly RAST): measures serum IgE to specific allergens. Similar limitations to SPT — detects sensitization, not necessarily clinical allergy.
• Oral food challenge (OFC): the gold standard. The patient consumes incrementally increasing doses of the allergen under medical supervision. Unambiguous but carries reaction risk. Double-blind placebo-controlled OFC is the definitive diagnostic tool in research settings.

Oral Immunotherapy — Peanut Allergy Treatment

Palforzia (peanut allergen powder-dnfp), approved by the FDA in January 2020 for ages 4–17, was the first approved treatment for peanut allergy. Oral immunotherapy (OIT) works by desensitizing the immune system through controlled daily peanut protein ingestion, starting at 0.5 mg and incrementally increasing over approximately 24 weeks to a 300 mg maintenance dose. The PALISADE trial showed 67% of treated participants could tolerate 600 mg of peanut protein (equivalent to roughly 2 peanuts) without severe symptoms, versus 4% of placebo recipients. Palforzia does not cure peanut allergy and does not eliminate anaphylaxis risk — patients must continue to carry epinephrine. OIT programs for milk, egg, and tree nut allergies are in active clinical development and use off-label.

This article is for informational purposes only. Consult a qualified healthcare professional.